|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7088 | (2013.01) | ||
| A61K 31/711 | (2006.01) | ||
| A61K 31/711 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Patento numeris | 3512525 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17851584.7 |
| Europos patento paraiškos padavimo data | 2017-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/051723 |
| Data | 2017-09-15 |
| (87) | Numeris | WO 2018/053232 |
| Data | 2018-03-22 |
| (30) | Numeris | Data | Šalis |
| 201662395680 P | 2016-09-16 | US | |
| 201762487277 P | 2017-04-19 | US |
| (72) |
ASHIZAWA, Ana Tari , US
|
| (73) |
Bio-Path Holdings, Inc. ,
4710 Bellaire Boulevard
Suite 210, Bellaire, TX 77401,
US
|
| (54) | COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES |
| COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES |